Different patterns of cerebral injury in dementia with or without diabetes
- PMID: 19139294
- PMCID: PMC2766529
- DOI: 10.1001/archneurol.2008.579
Different patterns of cerebral injury in dementia with or without diabetes
Abstract
Background: Diabetes mellitus (DM) increases the risk of dementia in the elderly. However, its underlying mechanisms, its connection with Alzheimer disease and vascular cognitive impairment, and effects of therapy remain unclear.
Objective: To test the hypothesis that DM promotes specific neuropathologic processes that contribute to dementia and that these processes may be suppressed by antidiabetic therapy.
Design: A comprehensive neuropathologic assessment of all cases from a community-based study of incident dementia (Adult Changes in Thought Study) that underwent autopsies (n = 259) and had information on DM status (n = 196). Biochemical analysis was conducted on a subset of these cases with rapidly frozen brain tissue (n = 57).
Participants: Autopsy cases were divided into 4 groups: no DM/no dementia (DM-/dementia-), DM/no dementia (DM+/dementia-), no DM/dementia (DM-/dementia+), and DM/dementia (DM+/dementia+). Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) diagnosis of dementia was assigned through a consensus of experts following biennial cognitive and physical evaluations. Diabetes was diagnosed based on information obtained from participants' extensive medical records.
Results: In cases without dementia (n = 125), neuropathologic and biochemical end points did not differ significantly by DM status. However, we observed 2 patterns of injury in patients with dementia (n = 71) by their DM status. Individuals without DM but with dementia (DM-/dementia+) had a greater amyloid-beta peptide load and increased levels of F(2)-isoprostanes in the cerebral cortex, while DM+/dementia+ patients had more microvascular infarcts and an increased cortical IL-6 (interleukin 6) concentration. The number of microvascular infarcts was greater in deep cerebral structures in patients with dementia whose diabetes was treated, whereas amyloid plaque load tended to be greater for untreated diabetic patients with dementia.
Conclusions: These novel characterizations of 2 different patterns of cerebral injury in patients with dementia depending on DM status may have etiologic and therapeutic implications. Published online January 12, 2009 (doi:10.1001/archneurol.2008.579).
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2766529/bin/nihms-114559-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2766529/bin/nihms-114559-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2766529/bin/nihms-114559-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2766529/bin/nihms-114559-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2766529/bin/nihms-114559-f0005.gif)
Comment in
-
Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease.Nat Rev Neurol. 2009 Jun;5(6):305-6. doi: 10.1038/nrneurol.2009.72. Nat Rev Neurol. 2009. PMID: 19498432
Similar articles
-
Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.JAMA Neurol. 2019 Jul 1;76(7):818-826. doi: 10.1001/jamaneurol.2019.0834. JAMA Neurol. 2019. PMID: 31009033 Free PMC article.
-
Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.J Neuropathol Exp Neurol. 2015 Feb;74(2):100-9. doi: 10.1097/NEN.0000000000000153. J Neuropathol Exp Neurol. 2015. PMID: 25575135 Free PMC article.
-
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721. JAMA Neurol. 2015. PMID: 26302353 Free PMC article.
-
Dementia in a retired world boxing champion: case report and literature review.Clin Neuropathol. 2009 Jul-Aug;28(4):275-80. Clin Neuropathol. 2009. PMID: 19642506 Review.
-
[Dementia and diabetes mellitus].Srp Arh Celok Lek. 2008 Mar-Apr;136(3-4):170-5. doi: 10.2298/sarh0804170p. Srp Arh Celok Lek. 2008. PMID: 18720754 Review. Serbian.
Cited by
-
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358. Int J Mol Sci. 2024. PMID: 38673943 Free PMC article. Review.
-
Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD).Sci Rep. 2024 Mar 12;14(1):6005. doi: 10.1038/s41598-024-56702-1. Sci Rep. 2024. PMID: 38472452 Free PMC article.
-
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders.Pharmaceuticals (Basel). 2023 Dec 11;16(12):1714. doi: 10.3390/ph16121714. Pharmaceuticals (Basel). 2023. PMID: 38139841 Free PMC article. Review.
-
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment.Sci Rep. 2023 Dec 17;13(1):22436. doi: 10.1038/s41598-023-49479-2. Sci Rep. 2023. PMID: 38105338 Free PMC article.
-
Metformin, age-related cognitive decline, and brain pathology.Neurobiol Aging. 2024 Jan;133:99-106. doi: 10.1016/j.neurobiolaging.2023.10.005. Epub 2023 Oct 17. Neurobiol Aging. 2024. PMID: 37931533
References
-
- Biessels GJ, Kappelle LJ. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans. 2005;33:1041–1044. - PubMed
-
- Boiten J, Luijckx GJ, Kessels F, Lodder J. Risk factors for lacunes. Neurology. 1996;47:1109–1110. - PubMed
-
- Heitner J, Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects: a retrospective postmortem immunocytochemical and histofluorescent study. Neurology. 1997;49:1306–1311. - PubMed
-
- MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2002;14:77–83. - PubMed